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 Impulse Oscillometry as a Predictor of 
Asthma Exacerbations in Young Children 
 Johannes Schulze a    Silke Biedebach a    Martin Christmann c    Eva Herrmann b    
Sandra Voss a    Stefan Zielen a 
 a  Department of Allergy, Pulmonology and Cystic Fibrosis, Children’s Hospital, and  b  Institute of Biostatistics and 
Mathematical Modeling, Goethe University,  Frankfurt am Main , Germany;  c  Children’s Hospital,  Zurich , Switzerland 
ficity combination for predicting an AE: FEV 1 103.2% (AUC 
0.62), BHR (PD 20 methacholine) 0.13 mg (AUC 0.61), and, in
54 children, Rrs5 0.78 kPa × l –1 × s (AUC 0.80). Logistic regres-
sion analysis demonstrated that the combination of all pa-
rameters predicted the individual risk of AEs with an accu-
racy of 86%.  Conclusions: IOS, a simple method, predicted 
the probability of AEs in young children. Airway resistance, 
measured by IOS, was superior to FEV 1 and methacholine 
testing. The current data suggest that peripheral airway ob-
struction is present during symptom-free periods and that 
these children more likely experience AEs. 
 © 2016 S. Karger AG, Basel 
 Introduction 
 In childhood asthma, acute exacerbations are one of 
the main causes for emergency department visits  [1–5] . 
Whereas the use of anti-inflammatory therapy in moder-
ate to severe asthmatics is well established, strategies to 
prevent asthma exacerbations (AEs) in young children 
with intermittent asthma are unclear. To avoid overtreat-
ment with anti-inflammatory medication, it is very im-
port to define risk factors that can predict further AEs, 
justifying costs and possible side effects of an asthma 
therapy during winter time. 
 Key Words 
 Pediatric asthma · Exacerbation · Predictors · Impulse 
oscillometry · Pediatric lung function testing · Methacholine 
inhalation challenge 
 Abstract 
 Background: In a post-hoc analysis of a pediatric asthma 
study, we identified the predictors of asthma exacerbations 
(AEs) and related them to forced expiratory volume (FEV 1 ), 
the FEV 1 /FVC ratio, and bronchial hyperresponsiveness 
(BHR).  Objectives: We sought to detect predictors of AEs in 
a prospective study that utilizes impulse oscillometry (IOS) 
and to compare the results to previously determined predic-
tors.  Methods: A moderate AE was defined as an increased 
use of salbutamol during coughing episodes. Pulmonary 
function and BHR were measured during symptom- and 
medication-free periods. Additionally, allergen testing and 
IOS were included. To calculate the sensitivity and specifici-
ty of AE detection, a receiver-operating characteristic (ROC) 
curve was plotted, and accuracy was measured with the area 
under the ROC curve (AUC). A logistic regression analysis was 
used to predict the probability of an exacerbation.  Results: 
Seventy-five pediatric patients (4–7 years of age) with inter-
mittent asthma were included. In 69 patients, the following 
cut-off values demonstrated the best sensitivity and speci-
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 Spirometry and methacholine challenge testing (MCT) 
are common predictors of AEs  [3] . In our previous study 
 [6] of 102 children (aged 4–7 years) with intermittent 
asthma, biomarkers and asthma characteristics were eval-
uated as predictors of treatment response either to mon-
telukast or fluticasone. The biomarkers were the forced 
expiratory volume in 1 s (FEV 1 ), the FEV 1 /FVC ratio, ex-
haled nitric oxide, and bronchial hyperresponsiveness 
(BHR) to methacholine. Forty-five percent of the chil-
dren experienced an AE during a one-year observation 
period. In a post-hoc analysis, FEV 1 , the FEV 1 /FVC ratio, 
and PD 20 methacholine significantly predicted moderate 
AEs. 
 The impulse oscillation system (IOS) is a simple, non-
invasive method requiring only passive patient coopera-
tion and may be useful in testing patients who cannot 
perform acceptable spirometry maneuvers  [7, 8] . IOS al-
lows for the evaluation of lung function through the mea-
surement of both airway resistance (Rrs) and airway re-
actance (Xrs)  [9, 10] . IOS generates pressure oscillations 
that are applied at a fixed (square wave) frequency of
5 Hz, from which all other frequencies of interest are de-
rived  [9] . The Rrs includes proximal and distal airways 
(central and peripheral), lung tissue, and chest wall resis-
tance  [11] . Low–frequency, capacitive Xrs essentially ex-
presses the ability of the respiratory tract to store capaci-
tive energy, primarily resident in the lung periphery. 
Thus, Xrs5 characterizes the lung periphery  [11] .
 Peripheral airways have much smaller lumina than 
central (large) airways, and inflammation/edema in the 
walls of peripheral airways can be expected to have a pro-
portionately larger effect on lumen size than inflamma-
tion/edema in larger airways  [11] . Many authors state 
that, when either proximal or distal airway obstruction 
occurs, Rrs5 and Xrs5 may be increased  [9, 11] , and high-
er-frequency oscillations, such as at 20 Hz, provide infor-
mation primarily concerning the central airways  [9] . As 
a consequence, the difference between Rrs5 and Rrs20 
(Rrs5–20) might be an index of the peripheral airways 
only  [12] . Although, these findings are still hypothetical, 
there is a body of evidence suggesting that the forced os-
cillation technique (FOT) is more sensitive than spirom-
etry to detect peripheral airway disease  [11] . Many re-
ports have found a frequency dependence of resistance 
and reactance in peripheral airways diseases, where the 
Rrs at low frequencies was greater than the Rrs at in-
creased oscillation frequencies  [13–17] .
 In 4-year-old children at risk of persistent asthma, 
Rrs5 after bronchodilator response differentiates between 
children with and those without asthma  [18] . Therefore, 
IOS/FOT is an alternative in young children, not only be-
cause oscillation techniques are more applicable in this 
age group, but also because body plethysmograph or 
MCT cannot be easily performed in many centers. 
 Predictive models use clinical variables, healthcare 
data, pulmonary function testing (PFT), and biomarkers 
 [4] . Data from young children are rare, because most 
studies only enroll children of the age of 6 years and old-
er, and the outcome parameters are usually severe and not 
moderate AEs. To the best of our knowledge, no study has 
investigated IOS as a possible predictor of AEs in this age 
group so far. A study of children between 0 and 14 years 
of age observed that oral steroid prescriptions and hospi-
talizations indicated an increased risk of future hospital-
ization  [5] . In school children, a lower FEV 1 /FVC ratio 
and the MCT were predictors of severe AEs  [3] . Given the 
heterogeneity of young children with intermittent asth-
ma and the urgency to identify only those with a high risk 
of AEs, we aimed to confirm our previous findings in a 
prospective cohort of 69 children with intermittent asth-
ma. Following the same design, the validation of FEV 1 , 
the FEV 1 /FVC ratio, and MCT were the aim, as well as a 
skin prick or a RAST test was performed. Additionally, 
IOS was measured to identify patients with an occult el-
evation of airway resistance and reactance. 
 Materials and Methods 
 Subjects 
 Seventy-five children (4–7 years old) were evaluated after being 
recruited in the summer from the outpatient clinic of the Depart-
ment of Allergy, Pulmonology and Cystic Fibrosis. All children 
were diagnosed with intermittent asthma by the investigator. The 
detailed patient history included asthma symptoms, comorbidi-
ties, allergies, and medication use. According to the GINA guide-
lines for asthma management and prevention in children 5 years 
and younger, symptom patterns were wheeze, cough, breathless-
ness, activity limitation, and nocturnal symptoms. Furthermore, 
the family history was recorded, particularly with regards to asth-
ma, hay fever, and atopic dermatitis. Children were eligible for the 
study if they had either three episodes of wheeze lasting >3 days 
(confirmed by either the primary-care doctor or the investigator), 
or one prolonged physician-confirmed wheezy episode treated 
with inhaled corticosteroid (ICS) with a daily minimum dose of 
100 μg fluticasone or 200 μg budesonide, or with leukotriene re-
ceptor antagonist (LTRA) for at least 6 weeks in the last 12 months. 
The parents were informed about the purpose, course, and aim of 
the study. 
 At the first visit, the children had to be free of infections during 
the previous 4 weeks according to the judgment of the investigator. 
Before the visit, short-acting beta-agonists were withdrawn for 8 h, 
ipratropium bromide and long-acting beta-agonists were with-
drawn for 48 h, and ICS and LTRA were withdrawn for 28 days. 
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 The study was approved by the Ethics Committee of Goethe 
University, and informed consent was obtained from the partici-
pants’ parents prior to the start of the study (clinical trials registra-
tion No.: NCT01449435).
 Study Design 
 This nonblinded, cross-sectional study is based on 1 office vis-
it and 6 telephone calls and took place between August 2011 and 
July 2012. At visit 1, baseline measurements were performed, in-
cluding PFT, IOS, and MCT, as well as a skin prick or a RAST test. 
At the beginning of the study, IOS was not measured (in 15 of 69 
patients), because IOS was only later added to the study protocol. 
The patients were followed for 1 year during the winter and spring 
seasons. The severity of the symptoms was calculated according to 
a validated pediatric asthma caregiver diary  [19] . The parents were 
instructed to record in a diary all asthma symptoms, including 
cough, shortness of breath, and wheezing, as well as the use of sal-
butamol and systemic steroids, and signs of infections (runny nose 
and fever). Moderate AEs were defined as the occurrence of asth-
ma symptoms and the use of salbutamol  ≥ 2 times per week or the 
use of  ≥ 5 puffs of salbutamol over a 2-week period  [6, 20] . The 
parents were contacted by telephone every 2 months.
 IOS and PFT  
 Using the Impulse Oscillometry System and Masterscreen 
(CareFusion, Hoechberg, Germany), IOS was measured first by a 
pulmonary function technician or by a trained PhD candidate. The 
system was calibrated daily as directed by the manufacturer. The 
mean of at least three technically acceptable maneuvers was deter-
mined. IOS data are presented as absolute values, they were ad-
justed for height and weight by the system according to the regres-
sion equations of Dencker et al.  [21] and are presented as the per-
cent of the predicted values. The intrameasurement repeatability 
is expressed as a coefficient of variation (CV)  [22] . The mean of at 
least three technically acceptable maneuvers was determined. 
 IOS was followed by spirometry. The flow-volume curves were 
inspected and visibly inadequate maneuvers were excluded. The 
start of the test has been quantified by calculating the back-extrap-
olated volume, and the forced expired time has been reported. A 
minimum of two acceptable flow volume loops were required, and 
the second highest FVC and FEV 1 were within 0.1 liters or 10% of 
the highest value  [22] . The predicted FEV 1 values were determined 
based on the reference values for children  [23] .
 Methacholine Challenge Testing 
 MCT was performed using the APS dosimeter technique 
(CareFusion, Hoechberg, Germany) with the Sidestream, Medic-
Aid nebulizer. The doses of inhaled methacholine, at a concentra-
tion of 16 mg/ml, were increased according to the following spec-
ifications (steps 1–5): 0.01, 0.1, 0.4, 0.8, and 1.6 mg. Therefore, the 
entire protocol called for the delivery of cumulative doses of 0.1, 
0.5, 1.3, and 2.9 mg. Two min after each inhalation, spirometry was 
performed. The individual provocation dose that caused a 20% 
drop in FEV 1 (PD 20 methacholine) was calculated by logarithmic 
interpolation  [24] .
 Statistical Analysis  
 For the statistical analyses, GraphPad Prism 5.01 (GraphPad 
Software, La Jolla, Calif., USA), BiAS for Windows version 11 (ep-
silon-Verlag; Darmstadt, Germany) and Microsoft Excel were 
used. The parameters were tested for normal and log-normal dis-
tributions using the Kolmogorov-Smirnov test. Fisher’s exact test 
was used to determine associations between the variables in the 
contingency tables. To define the sensitivity and specificity of a 
predictor for detecting an AE, a receiver-operating characteristic 
(ROC) curve was plotted. The cut-off levels were optimized using 
the Youden index (sensitivity + specificity – 1). The accuracy was 
measured with an area under the curve (AUC) analysis. The indi-
vidual probability of an AE was calculated by logistic and log-lo-
gistic regression analyses. All predictor variables that are useful in 
predicting the response variable were included  [25] . The Wald test 
was used to determine statistical significance for each of the inde-
pendent variables. In a stepwise regression, significant variables 
were added to the model/prediction and nonsignificant variables 
were removed. Probability (p) values  ≤ 0.05 were considered sta-
tistically significant.
 Based on the post-hoc analysis including 102 children, an FEV 1 
of 103.2% pred, an FEV 1 /FVC ratio of 89.7%, and a PD 20 metha-
choline of 0.13 mg significantly predicted an AE. In the analysis, 
17 of the 23 patients with 3 positive predictors and 5 of the 26 pa-
tients without positive predictors had AEs. To calculate the risk of 
exacerbation with an alpha of 0.05 and a beta of 0.20, each group 
required a minimum of 12 patients. Because 16.2% of the children 
had 3 risk factors, and 18.3% of the children lacked any risk factors, 
a total group size of 75 patients was determined to include 12 pa-
tients in each group.
 Results 
 Seventy-five pediatric patients were included, and 69 
patients completed the study protocol. Of these, 51 chil-
dren (73.9%) had a first-degree family history of asthma, 
allergic rhinitis, or atopic dermatitis. Three patients were 
excluded because they were treated with ICS or LTRA 
without having AEs. In 3 cases, the parents withdrew con-
sent. In the previous 12 months, 37 children (53.6%) had 
undergone therapy with ICS, 25 (36.2%) with LTRA, and 
7 (10.2%) with ICS and LTRA. During the observation 
period, 42 patients (60.9%) had an AE. The AE was de-
fined according to the inclusion criteria. Patients were ad-
vised to visit the study center immediately, and the AE 
was confirmed by the investigator. At the same time, the 
investigator decided about further asthma therapy.
 There was a trend of younger children having more 
exacerbations; however, in the total group, this trend was 
not statistically significant (p = 0.26). The baseline char-
acteristics of all children are summarized in  table 1 .
 Taken from the medical history of the 69 patients, 11 
children (15.9%) had allergic rhinitis, and 20 children 
(29.0%) had atopic dermatitis. Twenty-seven patients had 
a positive skin prick or RAST test; 8 were mono-sensi-
tized against grass, birch, alternaria, or mites; 6 had two 
sensitizations against grass/birch or mites/cats; and 13 
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had a positive test against  ≥ 3 allergens. More prick or 
RAST test-positive children had exacerbations (22 posi-
tive vs. 5 non-positive children, respectively), and the 
non-sensitized patients were equally divided into the ex-
acerbated and not-exacerbated groups (21 each). The dif-
ferences were statistically significant (p = 0.01), with a 
sensitivity of 51% (95% CI, 0.35–0.67) and a specificity of 
81% (95% CI, 0.61–0.93). 
 Table 2. Baseline pulmonary lung function, MCT, per protocol group (n = 69) and IOS measurements (n = 54)
Total Exacerbated Not-exacerbated p
FVC, % pred 105.0 ± 18.8 103.2 ± 20.6 108.1 ± 15.3 0.29
FEV1, % pred 106.6 ± 14.3 104.6 ± 13.9 110.5 ± 14.5 0.10
FEV1/FVC ratio, % 88.8 ± 10.5 88.0 ± 9.7 90.2 ± 11.8 0.41
PD20methacholine, mg 0.34 ± 0.55 0.27 ± 0.49 0.45 ± 0.63 0.18
Rrs5, kPa × l–1 × s 0.76 ± 0.19 0.84 ± 0.19 0.66 ± 0.15 <0.001
Rrs5, % pred 95.1 ± 28.0 103.5 ± 30.4 85.5 ± 21.6 <0.01
Xrs5, kPa × l–1 × s –0.28 ± 0.12 –0.32 ± 0.12 –0.24 ± 0.11 0.01
Xrs5, % pred 94.3 ± 46.6 104.9 ± 50.3 82.1 ± 39.5 0.07
Rrs5 – 20, kPa × l–1 × s 0.37 ± 0.14 0.30 ± 0.12 0.42 ± 0.13 <0.001
Values are given as means ± SD.
 Table 1.  Patient characteristics
Intention to treat Per protocol Exacerbated Not-exacerbated
Total 75 69 42 (60.9%) 27 (39.1%)
Male/female 43/32 38/31 24/18 19/8
Age, years 5.0 ± 0.82 5.0 ± 0.81 4.9 ± 0.83 5.1 ± 0.82
Age groups
4 – 5 years 25 23 16 7
5 – 6 years 25 24 14 10
6 – 7 years 25 22 12 10
Height, cm 114.8 ± 8.1 114.9 ± 8.3 114.1 ± 9.0 116.0 ± 6.8
Weight, kg 20.6 ± 3.9 21.2 ± 4.0 20.1 ± 4.1 21.9 ± 3.6
Values are given as numbers or means ± SD.
 Table 3. ROC analysis to detect an AE
Optimal 
cut-off point
Sensitivity 
(95% CI)
Specificity 
(95% CI)
AUC p
FEV1, % pred 100.9 0.43 (0.28 – 0.59) 0.74 (0.54 – 0.89) 0.61 0.10
FEV1/FVC ratio, % 94.9 0.48 (0.32 – 0.64) 0.56 (0.35 – 0.75) 0.54 0.58
PD20methacholine, mg 0.14 0.55 (0.38 – 0.71) 0.26 (0.11 – 0.46) 0.61 0.11
Rrs5, kPa × l–1 × s 0.76 0.68 (0.49 – 0.83) 0.83 (0.56 – 0.93) 0.78 <0.001
Rrs5, % pred 95.0 0.58 (0.39 – 0.75) 0.76 (0.55 – 0.90) 0.69 0.01
Xrs5, kPa × l–1 × s  – 0.4 0.29 (0.18 – 0.52) 1.0 (0.85 – 1.00) 0.70 0.01
Xrs5, % pred 128.8 0.32 (0.17 – 0.51) 0.92 (0.74 – 0.99) 0.61 0.14
Rrs5 – 20, kPa × l–1 × s 0.3 0.90 (0.74 – 0.98) 0.57 (0.34 – 0.77) 0.77 <0.001
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 Pulmonary Function Testing 
 The baseline PFT and MCT did not differentiate be-
tween the exacerbated and not-exacerbated groups. In 
three IOS measurements, the mean values, SD, and CV 
for Rrs5 and Xrs5 were 0.76 kPa × l –1 × s ± 0.19 (CV 
26.1%) and –0.28 kPa × l –1 × s ± 0.12 (CV 43.3 %), respec-
tively. In 54 patients, Rrs5, Xrs5, and Rrs5–20 differed 
significantly between the two groups ( table 2 ).
 AE Predictors  
 In the post-hoc analysis, FEV 1 , the FEV 1 /FVC ratio, 
and PD 20 methacholine predicted moderate AEs in a ROC 
analysis. This result was not confirmed by the present 
data, as all measurements did not significantly predict 
AEs ( table 3 ). Of the patients in this study, 16 had no pos-
itive predictors, 29 had 1, 17 had 2, and 7 had 3. Therefore, 
the calculated minimum of 12 patients was not reached 
in the groups with 3 positive predictors. To compare the 
groups, only the group with 0–1 risk factors, consisting of 
45 patients, and the group with 2–3 predictors, consisting 
of 24 patients, had sufficient statistical power. Fisher’s ex-
act test demonstrated no significant between-group dif-
ferences (p = 0.09). 
 In contrast, an Rrs5 level of 0.76 kPa × l –1 × s predicted 
an AE with a sensitivity of 68% and a specificity of 83%. 
The accuracy (AUC) was 0.78 (p < 0.001). An Xrs5 level 
of –0.4 kPa × l –1 × s predicted an AE with a sensitivity of 
29% and a specificity of 100% (AUC 0.70, p = 0.01), and 
an Rrs5–20 level of 0.3 kPa × l –1 × s predicted an AE with 
a sensitivity of 90% and a specificity of 57% (AUC 0.77, p 
< 0.001;  fig. 1 ,  table 3 ). Rrs5 and Xrs5 linearly declined 
with increasing height  [21] . However, the accuracy of the 
reference values of Rrs5 and Xrs5 was inferior to that of 
the absolute values ( table 3 ).
 Younger children have more AEs. In our study group, 
Spearman’s correlation test indicated that the coefficient 
of Rrs5 and height was r = –0.17 (p = 0.20). In the next 
step, we adjusted the Rrs5 values for height by the regres-
sion coefficient of –0.0037. The adjusted ROC analysis of 
Rrs5 revealed a sensitivity of 48.4% and a specificity of 
95.7% (AUC 0.76, 95% CI 0.64–0.89, p < 0.001). Xrs5 was 
less dependent on height, with a correlation coefficient 
r = –0.05. Therefore, we did not adjust the Xrs5 values for 
height.
 Logistic Regression Models 
 The different parameters were calculated in a stepwise 
logistic regression model. Rrs5 predicted an AE with an 
accuracy of 78%, and Xrs5 predicted an AE with an ac-
curacy of 70%. Adding the variables age, gender, and 
height to Rrs5, all three variables did not significantly in-
crease the predictive value of Rrs5. FEV 1 and PD 20 metha-
choline were not significant as single values, but they were 
significant combined in the stepwise regression. The 
1.0
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 Fig. 1. ROC curves and optimal cut-offs to predict an AE. An Rrs5 
value of 0.76 kPa × l –1 × s predicted an AE with a sensitivity of 68% 
and a specificity of 83% (AUC 0.80, p < 0.001), an Xrs5 value of 
–0.4 kPa × l –1 × s with a sensitivity of 29% and a specificity of 100% 
(AUC 0.70, p = 0.01), and an Rrs5–20 value of 0.3 kPa × l –1 × s with 
a sensitivity of 90% and a specificity of 57% (AUC 0.77, p < 0.001). 
 Table 4. Logistic regression to predict an AE
Predictor variables Regression 
coefficient
AUC (95% CI) p
FEV1 (% pred) –0.03 0.63 (0.49 – 0.77) 0.10
PD20methacholine (mg) –0.58 0.62 (0.48 – 0.76) 0.11
FEV1/FVC ratio (%) 0.003 0.54 (0.40 – 0.68) 0.57
Rrs5 (kPa × l–1 × s) 7.44 0.78 (0.68 – 0.92) <0.001
Xrs5 (kPa × l–1 × s) –7.90 0.70 (0.56 – 0.84) 0.01
FEV1 (% pred) –0.03 0.67 (0.53 – 0.80) 0.02PD20methachloline (mg) –0.54
Rrs5 (kPa × l–1 × s) 7.40 0.84 (0.74 – 0.95) <0.001FEV1 (% pred) –0.05
Rrs5 (kPa × l–1 × s) 7.56
0.87 (0.77 – 0.96) <0.001FEV1 (% pred) –0.05
PD20methacholine (mg) –1.33
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combination of Rrs5, FEV 1 , and PD 20 methacholine dem-
onstrated the best accuracy (i.e., 87%,  table 4 ) at p = 1 × 
(1 + exp[–0.5510 + (7.56 × Rrs5) + (–0.05 × FEV 1 ) + 
(–1.33 × PD 20 methacholine)]) –1 ; AUC = 0.87, p < 0.001).
 Discussion 
 In this study, we aimed to confirm predictors of AEs. 
In contrast to the post-hoc analysis, the biomarkers FEV 1 , 
FEV 1 /FVC ratio, and PD 20 methacholine did not predict 
AEs. However, IOS measured by simple maneuvers sig-
nificantly predicted the probability of AEs. To the best of 
our knowledge, we are the first group to report that IOS 
measurements have a high predictive value in this age 
group. The combination with spirometry and MCT in-
creased the accuracy in a logistic regression model. 
 In a large retrospective cohort study  [26] , FEV 1 was an 
independent predictor of asthma attacks. For children 
with an FEV 1 of 80–100% compared to children with an 
FEV 1 >100%, the odds ratios were 1.1 (CI, 1.0–1.2) in 
younger and 1.3 (CI, 1.1–1.4) in older patients. Decreas-
ing FEV 1 categories were associated with a progressive 
increase of individuals reporting an asthma attack. In the 
Childhood Asthma Management Program (CAMP)  [3] , 
the age at randomization, FEV 1 , the FEV 1 / FVC ratio, 
PC 20 methacholine, and the number of positive skin tests 
at randomization differed significantly between those 
subjects who had no severe exacerbations and those who 
had at least one severe exacerbation. 
 In our post-hoc analysis, the spirometric parameter, 
FEV 1 , was identified as a predictor of AE. In the prospec-
tive study, even when FEV 1 differed between the exacer-
bated and not-exacerbated groups, this failed to reach sig-
nificance because of the lower sensitivity. In the cited 
studies with significant outcomes  [3, 26] , more severe pa-
tients with lower FEV 1 values were investigated. In mild 
asthmatics, FEV 1 might not be sensitive enough to detect 
moderate AEs. 
 IOS measurement significantly predicted AEs. In re-
cent years, the clinical value of IOS and spirometry has 
been compared. In 4-year-old children at risk of persis-
tent asthma, Rrs5 after bronchodilator response differen-
tiated between children with and those without asthma 
 [18] . At the same time, there were no significant differ-
ences in the spirometric values. Song et al.  [27] confirmed 
these findings in 3- to 6-year-old children, and Komarow 
et al.  [28] confirmed these findings in 3- to 17-year-old 
children and adolescents. In another study, 6- to 17-year-
old children with controlled and uncontrolled asthma 
were compared  [29] . The IOS measurements (not the 
FEV 1 values) were significantly different between the two 
groups, and the authors hypothesized that the asthma 
control status primarily reflects small or peripheral air-
way obstruction. The same working group showed in the 
same age group that IOS significantly predicted children 
at risk of losing asthma control  [12] . Lowe et al.  [30] 
showed that 3-year-old children with a history of wheez-
ing had a significantly higher specific airway resistance
in body plethysmography than those who had never 
wheezed. In adults, using the multiple-breath nitrogen 
washout technique, asthma control was associated with 
small-airways disease  [31] . In addition, it has recently 
been shown in adults with asthma that the IOS parame-
ters Rrs5 and Rrs20, but not Rrs5–20 and AX, are associ-
ated with asthma severity, control, quality of life, and ex-
acerbations  [32] .
 The difference between ‘large central’ airways and 
‘small peripheral’ airways is neither precisely fixed ana-
tomically nor precisely defined in terms of airway lumen 
diameter  [11] . In children with respiratory symptoms 
who had not yet been diagnosed with asthma, early eo-
sinophilic inflammation and even remodeling of the air-
way wall has been detected in endobronchial biopsies 
 [33] . Transbronchal biopsy studies in children are obso-
lete. 
 Nevertheless, apart from lung function testing, high-
resolution computed tomography has allowed for the de-
tection of low-attenuation lung areas, which are believed 
to represent trapped air as a result of small airway closures 
 [34] . In this study by Jain et al.  [34] ,  significant correla-
tions between low-density areas on high-resolution com-
puted tomography and the IOS parameters Rrs5 and Xrs5 
were demonstrated in 21 children with mild to moderate 
asthma. FEV 1 and Rrs20 are more related to larger air-
ways, whereas Rrs5–20 and Xrs5 represent peripheral air-
ways. In our study, this result indicates that even during 
symptom-free intervals, impaired peripheral airways are 
present in children with intermittent asthma, and these 
children experience AEs during infections. As testing of 
the predictive value of IOS was not the primary aim of the 
study, the results are more exploratory than conclusive. 
Future studies are needed to confirm the results in a pro-
spective cohort.
 Shi et al.  [29] performed a ROC analysis, and an Rrs5 
value of 5.2 cm H 2 O × l –1 × s (= 0.51 kPa × l –1 × s, AUC 
0.71) and an Rrs5–20 value of 1.5 cm H 2 O × l –1 × s (= 0.15 
kPa × l –1 × s, AUC 0.86) best discriminated between con-
trolled and uncontrolled asthma. Concerning the predic-
tion of loss of asthma control  [12] , the accuracy of Rrs5 
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equaled our results (0.80 vs. 0.78), whereas the accuracy 
of Rrs5–20 was better (0.91 vs. 0.78) in Shi et al.’s study 
 [12] . The optimal cut-off points of 5.4 cm H 2 O × l –1 × s 
for Rrs5 (= 0.53 kPa × l –1 × s) and 1.0 cm H 2 O × l –1 × s for 
Rrs5–20 (= 0.1 kPa × l –1 × s) were lower than our results 
of 0.76 kPa × l –1 × s for Rrs5 and 0.3 kPa × l –1 × s for 
Rrs5–20 when predicting exacerbations. We, however, 
analyzed younger children, and resistance has been 
shown to correlate with height and to decrease in older 
children  [21, 29, 35] . Furthermore, the ROC analyses of 
Rrs5–20 and Xrs5 were superior to that of Rrs5  [12, 29] . 
In our study, the predictive accuracy of Rrs5 equaled that 
of Rrs5–20. Interestingly, in our study, the stratification 
for height only marginally altered the predictive value of 
Rrs5, indicating that Rrs5 is an independent parameter in 
this age group. In the ROC analysis, Xrs5 and the adjust-
ed Rrs5 values revealed a low sensitivity and a high spec-
ificity. Shi et al.  [12] showed that a lower cut-off point for 
Xrs5 (–1.8 kPa × l –1 × s) achieved a better balance between 
sensitivity and specificity. We found no examples for 
height-adjusted Rrs5 values in the literature.
 In our study, the absolute values of Rrs5 and Xrs5 were 
superior to the reference values. A comparison with the 
literature is difficult, because mainly absolute values are 
presented  [12, 18, 27, 29] . It is possible that a sample of 
360 children  [21] is not enough for exact reference values, 
and absolute values continue to be more precise. 
 In the study by Bisgaard and Klug  [7] that included 21 
young children aged 4–6 years, Rrs and Xrs both exhib-
ited the strongest response at 5 Hz during a methacholine 
challenge. Further studies showed equal responses of 
Rrs5 and Xrs5  [28, 29] , suggesting a close relationship be-
tween Rrs5 and Xrs5, as hyperinflation measured by Xrs5 
increases with increasing airway narrowing measured by 
Rrs5. 
 As a predictor of exacerbations, BHR has rarely been 
investigated in young children. In our study, similar to 
FEV 1 , PD 20 methacholine was not a significant predictor 
on its own. In the Pediatric Asthma Controller Trial 
(PACT)  [2] , PC 20 methacholine was not associated with 
exacerbations that required systemic corticosteroids or 
emergency care in mild to moderate asthmatics. Moder-
ate exacerbations were not considered outcome parame-
ters, and all patients received a controller medication that 
might have masked moderate AEs. In contrast, in the 
CAMP study  [3] , PC 20 methacholine was significantly as-
sociated with severe exacerbations, even after adjusting 
for ICS.
 Stepwise logistic regression models test the fit of a 
model after each coefficient is added or deleted  [25] . The 
combination of FEV 1 and PD 20 metacholine revealed a 
significant accuracy on a low level, indicating that both 
predictors have implications. After adding both param-
eters to Rrs5, the individual probability for predicting a 
moderate AE increased.
 Compared with non-atopic children, we found that 
atopy was a specific risk factor for AEs. Children (3–17 
years old) who were admitted to the hospital with an 
acute AE were significantly more sensitized than controls 
with stable asthma or inpatient controls  [36] . In the 
CAMP study  [3] , the number of positive skin tests dif-
fered significantly between subjects with 0 exacerbations 
and those with 1 severe exacerbation. In the MAAS study 
 [30] , atopic children had a higher specific airway resis-
tance than non-atopic children.
 The current study has some limitations. We could not 
confirm the hypothesis that children with 2–3 positive 
predictors (FEV 1 , FEV 1 /FVC ratio, and PD 20 methacho-
line) have more exacerbations than children with 0–1 
positive predictors. Children with 0–1 positive predictors 
had more AEs, as expected; and only 7 children had 3 
positive predictors, as opposed to the 12 calculated pa-
tients. Another limitation is the lack of data on post-bron-
chodilator reactivity. We did not define the IOS measure-
ments as a primary outcome parameter. IOS was later in-
cluded in the study; thus, it was measured in 54 of 69 
patients. The highly significant between-group difference 
and 80% accuracy for differentiating between patients 
with and those without exacerbations demonstrate the 
prognostic value of the IOS measurements. In compari-
son, a questionnaire for predicting severe AEs in the 
CAMP cohort had an accuracy of 69%  [4] .
 Conclusions 
 The single parameters FEV 1 , FEV 1 /FVC ratio, and 
BHR failed to predict moderate AEs in young children 
with asthma. In contrast, IOS was superior to spirometry 
and MCT with highly significant accuracy. In a stepwise 
regression, FEV 1 and MCT increased the predictive value 
of Rrs5. As Rrs5–20 and Xrs5 represent peripheral airway 
obstruction and hyperinflation, respectively, there is evi-
dence that the impairment of small airways is present 
even in the absence of symptoms. Future studies on AEs 
should include small airway measurements, such as IOS, 
body plethysmography, or the lung clearance index raised 
by the multiple breath washout test. In airway narrowing 
due to inflammation, the washout might take longer to 
complete, requiring a greater number of breaths  [37] . 
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